Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:Any
Updated:1/26/2019
Start Date:September 25, 2018
End Date:December 2019
Contact:Joseph Gwin, PhD
Email:info@biosensics.com
Phone:888-589-6213

Use our guide to learn which trials are right for you!

Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease

The principal means of measuring motor impairment in Huntington disease (HD) is the Unified
Huntington's Disease Rating Scale (UHDRS) total motor score, which is subjective,
categorical, requires significant training to administer correctly, and only captures
impairments in clinic. In this Direct to Phase II SBIR we will develop a wearable sensor
system for objective, sensitive, and continuous assessment of Huntington's chorea during
activities of daily living. The developed technology could be used clinically to detect
changes in motor function in response to medications, or could be used scientifically to
expedite and reduce the cost of early stage pharmaceutical clinical trials.


Inclusion Criteria:

- CAG expansion ≥ 36

Exclusion Criteria:
We found this trial at
1
site
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Phone: 585-276-6825
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials